Recent News

• 06.11.2025 - 46th Annual Goldman Sachs Global Healthcare Conference
• 06.04.2025 - Jefferies Global Healthcare Conference
• 05.28.2025 - 4DMT to Participate in Upcoming Investor Conferences
• 05.21.2025 - RBC 2025 Global Healthcare Conference
• 05.16.2025 - 4DMT Announces New Employment Inducement Grants
• 05.14.2025 - BofA Securities 2025 Healthcare Conference
• 05.08.2025 - 4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
• 05.05.2025 - 4DMT to Participate in Upcoming Investor Conferences
• 05.01.2025 - 4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME
• 04.11.2025 - 4DMT Announces New Employment Inducement Grants

Recent Filings

• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.08.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 05.08.2025 - 8-K Current report
• 05.08.2025 - EX-99.1 EX-99.1
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.29.2025 - ARS Annual Report to Security Holders
• 04.29.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.29.2025 - DEF 14A Other definitive proxy statements
• 04.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors